Glucose dysregulation and neurological injury biomarkers in critically ill children

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 10, 2010, Pages 4669-4679

  Vanhorebeek, Ilse ^a   Gielen, Marijke ^a   Boussemaere, Magaly ^a   Wouters, Pieter J ^a   Grandas, Fabian Guiza ^a   Mesotten, Dieter ^a   Van Den Berghe, Greet ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; NEURON SPECIFIC ENOLASE; PROTEIN S100B;

ADOLESCENT; ARTICLE; ASTROCYTE; BRAIN INJURY; CASE CONTROL STUDY; CHILD; CLINICAL TRIAL; CONTROL GROUP; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DISEASE MARKER; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INFANT; INSULIN TREATMENT; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; UNIVERSITY HOSPITAL;

EID: 77957790024     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-0805     Document Type: Article

References (46)

1. Cochran A, Scaife ER, Hansen KW, Downey EC 2003 Hyperglycemia and outcomes from pediatric traumatic brain injury. J Trauma 55:1035-1038 (Pubitemid 38044117)
2. Hall NJ, Peters M, Eaton S, Pierro A 2004 Hyperglycemia is associated with increased morbidity and mortality rates in neonates with necrotizing enterocolitis. J Pediatr Surg 39:898-901 (Pubitemid 38833778)
3. Faustino EV, Apkon M 2005 Persistent hyperglycemia in critically ill children. J Pediatr 146:30-34 (Pubitemid 40091727)
4. Branco RG, Garcia PC, Piva JP, Casartelli CH, Seibel V, Tasker RC 2005 Glucose level and risk of mortality in pediatric septic shock. Pediatr Crit Care Med 6:470-472 (Pubitemid 40980830)
5. Yates AR, Dyke 2nd PC, Taeed R, Hoffman TM, Hayes J, Feltes TF, Cua CL 2006 Hyperglycemia is a marker for poor outcome in the postoperative pediatric cardiac patient. Pediatr Crit Care Med 7:351-355 (Pubitemid 44048279)
6. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R 2001 Intensive insulin therapy in critically ill patients.NEngl J Med 345:1359-1367
7. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R 2006 Intensive insulin therapy in the medical ICU. N Engl J Med 354: 449-461 (Pubitemid 43200296)
8. Brunkhorst FM, Engel C, Bloos F, Meier-Hellman A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K 2008 Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 358:125-139
9. Preiser JC, Devos P, Ruiz-Santana S, Mélot C, Annane D, Groeneveld J, Iapichino G, Leverve X, Nitenberg G, Singer P, Wernerman J, Joannidis M, Stecher A, Chioléro R 2009 A prospective randomised multi-centre controlled trialontight glucose controlbyintensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med 35:1738-1748
10. NICE-SUGAR Study Investigators, Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, Hébert PC, Heritier S, Heyland DK, McArthur C, McDonald E, Mitchell I, Myburgh JA, Norton R, Potter J, Robinson BG, Ronco JJ 2009 Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360:1283-1297
11. Ryan CM, Atchison J, Puczynski S, Puczynski M, Arslanian S, Becker D 1990 Mild hypoglycemia associated with deterioration of mental efficiency in children with insulin-dependent diabetes mellitus. J Pediatr 117:32-38 (Pubitemid 20217490)
12. Bjørgaas M, Gimse R, Vik T, Sand T 1997 Cognitive function in type 1 diabetic children with and without episodes of severe hypoglycaemia. Acta Paediatr 86:148-153 (Pubitemid 27086765)
13. Duning T, van den Heuvel I, Dickmann A, Vokert T, Wempe C, Rienholze J, Loohmann H, Freise H, Ellger B 2010 Hypoglycemia aggravates critical illness-induced neurocognitive dysfunction. Diabetes Care 33:639-644
14. The Diabetes Control and Complicatons Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group, Jacobson AM, Musen G, Ryan CM, Silvers N, Cleary P, Waberski B, Burwood A, Weinger K, Bayless M, Dahms W, Harth J 2007 Long-term effect of diabetes and its treatment on cognitive function. N Engl J Med 356:1842-1852
15. Malone JI, Hanna S, Saporta S, Mervis RF, Park CR, Chong L, Diamond DM 2008 Hyperglycemia, not hypoglycemia, alters neuronal dendrites and impairs spatial memory. Pediatr Diabetes 9:531-539
16. Meyfroidt G, Keenan DM, Wang X, Wouters PJ, Veldhuis JD, Van den Berghe G 2010 Dynamic characteristics of blood glucose time series during the course of critical illness: effects of intensive insulin therapy and relative association with mortality. Crit Care Med 38: 1021-1029
17. Vriesendorp TM, DeVries JH, van Santen S, Moeniralam HS, de Jonge E, Roos YB, Schults MJ, Rosendaal FR, Hoekstra JB 2006 Evaluation of short-term consequences of hypoglycemia in an intensive care unit. Crit Care Med 34:2714-2718 (Pubitemid 44610935)
18. Brown TC, Connelly JF, Dunlop ME, McDougall PN, Tibballs J 1980 Fasting plasma glucose in children. Aust Paediatr J 16:28-29
19. Vlasselaers D, Milants I, Desmet L, Wouters PJ, Vanhorebeek I, van den Heuvel I, Mesotten D, Casaer MP, Meyfroidt G, Ingels C, Muller J, Van Cromphaut S, Schetz M, Van den Berghe G 2009 Intensive insulin therapy for patients in paediatric intensive care: a prospective, randomised controlled study. Lancet 373:547-556
20. Beardsall K, Vanhaesebrouck S, Ogilvy-Stuart AL, Vanhole C, Palmer CR, van Weissenbruch M, Midgley P, Thompson M, Thio M, Cornette L, Ossuetta I, Iglesias I, Theyskens C, de Jong M, Ahluwalia JS, de Zegher F, Dunger DB 2008 Early insulin therapy in very-low-birth-weight infants. N Engl J Med 359:1873-1884
21. Kochanek PM, Berger RP, Bayir H, Wagner AK, Jenkins LW, Clark RSB 2008 Biomarkers of primary and evolving damage in traumatic and ischemic brain injury: diagnosis, prognosis, probing mechanisms, and therapeutic decision making. Curr Opin Crit Care 14: 135-141 (Pubitemid 351498777)
22. Leviton A, Dammann O 2002 Brain damage markers in children. Neurobiological and clinical aspects. Acta Paediatr 91:9-13
23. Jenkins KJ, Gauvreau K, Newburger JW, Spray TL, Moller JH, Iezzoni LI 2002 Consensus-based method for risk adjustment for surgery for congenital heart disease. J Thorac Cardiovasc Surg 123: 110-118
24. Berger RP 2006 The use of serum biomarkers to predict outcome after traumatic brain injury in adults and children. J Head Trauma Rehabil 21:315-333
25. Fassbender K, Schmidt R, Schreiner A, Fatar M, Mühlhauser F, Daffertshofer M, Hennerici M 1997 Leakage of brain-originated proteins in peripheral blood: temporal profile and diagnostic value in early ischemic stroke. J Neurol Sci 148:101-105 (Pubitemid 27149530)
26. Georgiadis D, Berger A, Kowatschev E, Lautenschläger C,Börner A, Lindner A, Schulte-Mattler W, Zerkowski HR, Zierz S, Deufel T 2000 Predictive value of S-100β and neuron-specific enolase serum levels for adverse neurologic outcome after cardiac surgery. J Thorac Cardiovasc Surg 119:138-147
27. Suh SW, Gum ET, Hamby AM, Chan PH, Swanson RA 2007 Hypoglycemic neuronal death is triggered by glucose reperfusion and activation of neuronal NADPH oxidase. J Clin Invest 117:910-918
28. Erb MA, Heinemann MK, Wendel HP, Häberle L, Sieverding L, Speer CP, Ziemer G 2000 S-100 after correction of congenital heart defects in neonates: is it a reliable marker for cerebral damage? Ann Thorac Surg 69:1515-1519
29. Kapural M, Krizanac-Bengez Lj, Barnett G, Perl J, Masaryk T, Apollo D, Rasmussen P, Mayberg MR, Janigro D 2002 Serum S-100β as a possible marker of blood-brain barrier disruption. Brain Res 940:102-104
30. Marchi N, Cavaglia M, Fazio V, Bhudia S, Hallene K, Janigro D 2004 Peripheral markers of blood-brain barrier damage. Clin Chim Acta 342:1-12
31. Beers SR, Berger RP, Adelson PD 2007 Neurocognitive outcome and serum biomarkers in inflicted versus non-inflicted traumatic brain injury in young children. J Neurotrauma 24:97-105
32. Spinella PC, Dominguez T, Drott HR, Huh J, McCormick L, Rajendra A, Argon J, McIntosh T, Helfaer M 2003 S-100β protein serum levels in healthy children and its association with outcome in pediatric traumatic brain injury. Crit Care Med 31:939-945
33. Hsu AA, Fenton K, Weinstein S, Carpenter J, Dalton H, Bell MJ 2008 Neurological injury markers in children with septic shock. Pediatr Crit Care Med 9:245-251
34. Hovsepyan MR, Haas MJ, Boyajyan AS, Guevorkyan AA, Mamikonyan AA, Myers SE, Mooradian AD 2004 Astrocytic and neuronal biochemical markers in the sera of subjects with diabetes mellitus. Neurosci Lett 369:224-227
35. Strachan MWJ, Abraha HD, Sherwood RA, Lammie GA Deary IJ, Ewing FM, Perros P, Frier BM 1999 Evaluation of serum markers of neuronal damage following severe hypoglycaemia in adults with insulin-treated diabetes mellitus. Diabetes Metab Res Rev 15:5-12
36. Sulter G, Elting JW, De Keyser J 1998 Increased serum neuron specific enolase concentrations in patients with hyperglycemic cortical ischemic stroke. Neurosci Lett 253:71-73
37. Gerlach R, Demel G, König HG, Gross U, Prehn JH, Rabbe A, Seifert V, Kögel D 2006 Active secretion of S100B from astrocytes during metabolic stress. Neuroscience 141:1697-1701
38. Gürsoy M, Büyükuysal RL 2010 Mechansisms of S100b release from rat cortical slices determined under basal and stimulated conditions. Neurochem Res 35:429-436
39. Fontella FU, Cimarosti H, Crema LM, Thomazi AP, Leite MC, Salbego C, Gonçalves CA, Wofchuk S, Dalmaz C, Netto CA 2005 Acute and repeated restraint stress influences cellular damage in rat hippocampal slices exposed to oxygen and glucose deprivation. Brain Res Bull 65:443-450
40. Vlasselaers D, Mesotten D, Langouche L, Vanhorebeek I, van den Heuvel I, Milants I, Wouters P, Wouters P, Meyens B, Bjerre M, Hansen TK, Van den Berghe G 2010 Tight glycemic control protects the myocardium and reduces inflammation in neonatal heart surgery. Ann Thorac Surg 90:22-29
41. Van den Berghe G, Wilmer A, Milants I, Wouters PJ, Bouckaert B, Bruyninckx F, Bouillon R, Schetz M 2006 Intensive insulin therapy in mixed medical/surgical intensive care units. Benefit versus harm. Diabetes 55:3151-3159
42. Kosiborod M, Inzucchi SE, Goyal A, Krumholz HM, Masoudi FA, Xiao L, Spertus JA 2009 Relationship between spontaneous and iatrogenic hypoglycemia and mortality in patients hospitalized with acute myocardial infarction. JAMA 301:1556-1564
43. Van den Berghe G, Schoonheydt K, Becx P, Bruyninckx F, Wouters PJ 2005 Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology 64:1348-1353
44. de Ferranti S, Gauvreau K, Hickey PR, Jonas RA, Wypij D, du Plessis A, Bellinger DC, Kuban K, Newburger JW, Laussen PC 2004 Intraoperative hyperglycemia during infant cardiac surgery is not associated with adverse neurodevelopmental outcomes at 1, 4 and 8 years. Anesthesiology 100:1345-1352
45. Northam EA, Rankins D, Cameron FJ 2006 Therapy insight: the impact of type 1 diabetes on brain development and function. Nat Clin Pract Neurol 2:78-86
46. Wysocki T, Harris MA, Mauras N, Fox L, Taylor A, Jackson SC, White NH 2003 Absence of adverse effects of severe hypoglycemia on cognitive function in school-aged children with diabetes over 18 months. Diabetes Care 26:1100-1105